Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
05/17/2006 | EP1507519B1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
05/17/2006 | EP1506228A4 Role of p62 in aging-related disease |
05/17/2006 | EP1363652B1 Extract of green coffee beans, pharmaceutical composition containing this extract, use for the treatment of depression and alcoholism as well as its process of preparation |
05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
05/17/2006 | EP1349864B1 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1274711B1 New aza-indolyl derivatives |
05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
05/17/2006 | EP1263438B1 Neutral antagonists and use thereof in treating drug abuse |
05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
05/17/2006 | EP1135411B1 Methods and compositions for treating disorders involving excitotoxicity |
05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
05/17/2006 | EP0937077B1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
05/17/2006 | EP0716610B1 Human bone morphogenetic proteins for use in neural regeneration |
05/17/2006 | CN1774635A Anti-epileptogenic agents |
05/17/2006 | CN1774449A Inhibitors of MEMAPSIN2 and use thereof |
05/17/2006 | CN1774443A Phosphates of secondary alcohols |
05/17/2006 | CN1774437A 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
05/17/2006 | CN1774422A 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
05/17/2006 | CN1774281A Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
05/17/2006 | CN1774267A Amyloid-binding, metal-chelating agents |
05/17/2006 | CN1774265A Drug for nerve regeneration |
05/17/2006 | CN1774254A Phosphate derivatives of pharmaceutical products |
05/17/2006 | CN1774252A Phospholipid derivatives of valproic acid and mixtures thereof |
05/17/2006 | CN1774251A Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
05/17/2006 | CN1772753A Chinese medicine active compound component for treating senile dementia and its prepn and use |
05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
05/17/2006 | CN1772738A Crystalline Alipiprazole and its prepn |
05/17/2006 | CN1772263A Neurosism treating medicine |
05/17/2006 | CN1772246A Antialcoholic Chinese medicine |
05/17/2006 | CN1772224A Chinese herbal medicine decoction for treating spleen deficiency wefness type senile shaking palsy and its prepn |
05/17/2006 | CN1772220A Chinese herbal medicine decoction for treating endogenous wind type hemiplegia and its prepn |
05/17/2006 | CN1772206A Chinese medicine composition for preventing and treating senile dementia and prostate hypertrophy |
05/17/2006 | CN1772205A Chinese herbal medicine decoction for treating liver-Yang sthenia type hemiplegia and its prepn |
05/17/2006 | CN1772188A Chinese herbal medicine decoction for treating heart and spleen deficiency type insomnia and its prepn |
05/17/2006 | CN1772187A Chinese herbal medicine decoction for treating Yin deficiency and fire hyperactivity type insomnia and its prepn |
05/17/2006 | CN1772186A Chinese herbal medicine decoction for treating liver-kidney Yin deficiency type senile shaking palsy and its prepn |
05/17/2006 | CN1772141A Chinese herbal medicine decoction for treating wind-phlegm obstruction type hemiplegia and its prepn |
05/17/2006 | CN1772131A Chinese herbal medicine decoction for treating vital energy deficiency type hemiplegia and its prepn |
05/17/2006 | CN1772113A Neurosism treating Chinese medicine |
05/17/2006 | CN1772112A Tranquilizing medicine or health food composition |
05/17/2006 | CN1772107A Chinese herbal medicine decoction for treating Qi deficiency blood stasis type senile tremor and palsy and its prepn |
05/17/2006 | CN1772106A Chinese herbal medicine decoction for treating liver energy stagnation type insomnia and its prepn |
05/17/2006 | CN1772103A Chinese herbal medicine decoction for treating blood deficiency low fever and its prepn |
05/17/2006 | CN1772090A Quality control method for shinyleaf yellowhorn fruit kernel cream |
05/17/2006 | CN1772061A Chinese herbal medicine decoction for treating kidney-yin deficiency type hemiplegia and its prepn |
05/17/2006 | CN1772060A Chinese herbal medicine decoction for treating blood deficiency type hemiplegia and its prepn |
05/17/2006 | CN1772032A Application of sea-buckthorn fruit oil and sea-buckthorn leaf in preparing medicine for treating depression |
05/17/2006 | CN1772018A Quality control method for speedwell flavone capsule |
05/17/2006 | CN1772012A Freeze dried ginkgo leaf powder for injection and its prepn |
05/17/2006 | CN1771992A Brain extract and its prepn and use |
05/17/2006 | CN1771967A Oryzanol liposome and its prepn |
05/17/2006 | CN1771950A Freeze dried nimodipine composition and its prepn |
05/17/2006 | CN1771949A Soft nimodipine capsule and its prepn |
05/17/2006 | CN1771929A Treatment of pcp addiction and pcp addiction-related behavior |
05/17/2006 | CN1771921A Control releasing venlafaxine hydrochloride tablet and its prepn |
05/17/2006 | CN1771920A Oral disintegrated sertraline tablet and its prepn |
05/17/2006 | CN1256337C Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
05/17/2006 | CN1256145C External use plaster for treating peripheral prosopoplegia |
05/17/2006 | CN1256142C Chinese medicine for treating side reaction caused by insanity resisting medicine and its preparation method |
05/17/2006 | CN1256135C Medicine for treating cardiovascular and cerebrovascular disease and its preparing process |
05/17/2006 | CN1256126C Composition of Chinese traditional medicine for curing vascular dementia and preparation method |
05/17/2006 | CN1256110C Chinese medicine for expelling stasis |
05/17/2006 | CN1256098C Process for preparing livestock animal brain fat composite medicine |
05/17/2006 | CN1256097C Yak-blood deproteined extract and its extraction method and use thereof |
05/17/2006 | CN1256090C Application in antidepressants preparation of asiatic acid and derivative |
05/17/2006 | CN1256086C Use of 5-hydroxymethyl furfural in preparation of drug for nerve system |
05/17/2006 | CN1256085C Sertraline salts and substained-release dosage forms of sertraline |
05/16/2006 | US7045661 Crystalline forms of venlafaxine hydrochloride |
05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
05/16/2006 | US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives |
05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
05/16/2006 | US7045621 Process for producing dibenzothiazepine derivatives |
05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
05/16/2006 | US7045540 Selective estrogen receptor modulators |
05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
05/16/2006 | US7045538 Neurotransmitter moderator; analgesics; using n-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine |
05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
05/16/2006 | US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives |
05/16/2006 | US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
05/16/2006 | US7045520 Opioid receptor active compounds |
05/16/2006 | US7045517 Triazine compounds |
05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
05/16/2006 | US7045499 Therapeutic agent |